Biothera Pharmaceuticals Presents Data Broadening Imprime PGG Mechanism of Action
13 nov. 2017 09h30 HE
|
Biothera Pharmaceuticals, Inc.
Reduces expression of IDO, a potent suppressor of an anti-cancer T cell response Supplementation with IVIG boosts biomarker levels, restoring Imprime-driven pharmacodynamic responses EAGAN, Minn.,...